Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

Click for more information

0.00%

8.0¢ kazia therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-3

First 3 Last

Share
Profile

Follow
rroodd

1,080 Posts.

122

31/10/22

20:29

Post #: 64509596
Share

Originally posted by Gofish1: ↑

Financial Position
Kazia closed the quarter to 30 September 2022 with a cash balance on hand of A$5.3 million(approximately US$3.4 million), a decrease of A$1.7 million on the previous quarter. On a conservative forward-looking forecast, the company projects runway to 1Q CY2023.
However, the company notes that future expenditure will be significantly reduced due to the removal of costs associated with Stage 2 of the GBM AGILE study. The remaining part of GBM AGILE is fully-funded and the company anticipates no material further expenditure on the study.
The company continues to periodically use its NASDAQ ATM financing facility in a judicious way to support its operational requirements. The ATM allows the company to raise capital dynamically in the market, with no discount, no warrant coverage, and modest banking fees, allowing it to fund itself with minimal dilution to existing shareholders.

Expand

I think, considering Kazia's parilous finacial position that it is extremely generous of the long suffering shareholders to continue funding the very generous CEO/Board packages and options.

KZA Price at posting: 13.5¢ Sentiment: Sell Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 24 more messages in this thread...

First 3 Last

Add KZA (ASX) to my watchlist